165 related articles for article (PubMed ID: 24852617)
21. [Anaplastic large cell lymphoma associated with tuberculoid granulomatous reaction: report of a case].
Li SM
Zhonghua Bing Li Xue Za Zhi; 2006 Feb; 35(2):124-5. PubMed ID: 16630494
[No Abstract] [Full Text] [Related]
22. [Diagnosis and treatment of large-cell anaplastic lymphoma in children].
Makhonova LA; Peterson IS; Tupitsyn NN; Slugin AI; Matveeva II; Kiselev AV
Vestn Ross Akad Med Nauk; 2000; (6):8-10. PubMed ID: 10943152
[TBL] [Abstract][Full Text] [Related]
23. Primary ALK-positive anaplastic large cell lymphoma of the breast: a case report and review of the literature.
Daneshbod Y; Oryan A; Khojasteh HN; Rasekhi A; Ahmadi N; Mohammadianpanah M
J Pediatr Hematol Oncol; 2010 Mar; 32(2):e75-8. PubMed ID: 20168249
[TBL] [Abstract][Full Text] [Related]
24. ALK-negative systemic anaplastic large cell lymphoma: differential diagnostic and prognostic aspects--a review.
ten Berge RL; Oudejans JJ; Ossenkoppele GJ; Meijer CJ
J Pathol; 2003 May; 200(1):4-15. PubMed ID: 12692835
[TBL] [Abstract][Full Text] [Related]
25. Primary neutrophil-rich, CD30-positive anaplastic large cell lymphoma of the stomach: case report and review of the literature.
Kahaleh M; Hermans P; Buset M; Dargent JL
Acta Gastroenterol Belg; 2002; 65(4):237-40. PubMed ID: 12619433
[TBL] [Abstract][Full Text] [Related]
26. CD30 as a therapeutic target for lymphoma.
Schirrmann T; Steinwand M; Wezler X; Ten Haaf A; Tur MK; Barth S
BioDrugs; 2014 Apr; 28(2):181-209. PubMed ID: 24043362
[TBL] [Abstract][Full Text] [Related]
27. Clinical roundtable monograph: CD30 in lymphoma: its role in biology, diagnostic testing, and targeted therapy.
Sotomayor EM; Young KH; Younes A
Clin Adv Hematol Oncol; 2014 Apr; 12(4 Suppl 10):1-22. PubMed ID: 24870054
[TBL] [Abstract][Full Text] [Related]
28. Herpes zoster histopathologically mimicking CD30-positive anaplastic large cell lymphoma.
Shiohara J; Koga H; Uhara H; Takata M; Saida T; Uehara T
J Eur Acad Dermatol Venereol; 2009 May; 23(5):618-9. PubMed ID: 18759786
[No Abstract] [Full Text] [Related]
29. ALK1 as a novel therapeutic target for CD30⁺ T-anaplastic large cell lymphoma.
Hsu JW; Dang NH
J Natl Cancer Inst; 2014 Feb; 106(2):djt454. PubMed ID: 24491304
[No Abstract] [Full Text] [Related]
30. Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma presenting as a bladder neoplasm.
Gómez-Román JJ; Cobo ML; Val-Bernal JF
Pathol Int; 2008 Apr; 58(4):249-52. PubMed ID: 18324919
[TBL] [Abstract][Full Text] [Related]
31. Systemic anaplastic large cell lymphoma presenting with conjunctival involvement.
Clarke B; Legodi E; Chrystal V; Govender D
Arch Ophthalmol; 2003 Apr; 121(4):568-70. PubMed ID: 12695256
[No Abstract] [Full Text] [Related]
32. Two cases of CD30+, anaplastic lymphoma kinase (ALK)-negative anaplastic large cell lymphoma with oral manifestations.
Grandhi A; Boros AL; Berardo N; Reich RF; Freedman PD
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Feb; 115(2):e41-7. PubMed ID: 22940020
[TBL] [Abstract][Full Text] [Related]
33. Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas.
Younes A; Bartlett NL; Leonard JP; Kennedy DA; Lynch CM; Sievers EL; Forero-Torres A
N Engl J Med; 2010 Nov; 363(19):1812-21. PubMed ID: 21047225
[TBL] [Abstract][Full Text] [Related]
34. Small cell variant of anaplastic large cell lymphoma diagnosed by a novel chromosomal abnormality t(2;5;3)(p23;q35;p21) of bone marrow cells.
Sano F; Tasaka T; Nishimura H; Akiyama T; Kubo Y; Matsuhashi Y; Wada H; Sugihara T; Sadahira Y
Pathol Int; 2008 Aug; 58(8):494-7. PubMed ID: 18705769
[TBL] [Abstract][Full Text] [Related]
35. Fatal ALK-negative systemic anaplastic large cell lymphoma presenting with disseminated cutaneous dome-shaped papules and nodules.
Bird JE; Leitenberger JJ; Solomon A; Blauvelt A; Hopkins S
Dermatol Online J; 2012 May; 18(5):5. PubMed ID: 22630575
[TBL] [Abstract][Full Text] [Related]
36. ALK-positive large B-cell lymphoma with strong CD30 expression; a diagnostic pitfall and resistance to brentuximab and crizotinib.
Mehra V; Pomplum S; Ireland R; Yallop D; Devereux S; Marcus R; Shah C; Patten P; Kassam S
Histopathology; 2016 Nov; 69(5):880-882. PubMed ID: 27238948
[No Abstract] [Full Text] [Related]
37. ALK-negative anaplastic large cell lymphoma with CNS involvement needs more than just brentuximab vedotin.
Abid MB; Wang S; Loi HY; Poon LM
Ann Hematol; 2016 Oct; 95(10):1725-6. PubMed ID: 27460479
[No Abstract] [Full Text] [Related]
38. Severe cytokine release syndrome after the first dose of Brentuximab Vedotin in a patient with relapsed systemic anaplastic large cell lymphoma (sALCL): a case report and review of literature.
Alig SK; Dreyling M; Seppi B; Aulinger B; Witkowski L; Rieger CT
Eur J Haematol; 2015 Jun; 94(6):554-7. PubMed ID: 24913471
[TBL] [Abstract][Full Text] [Related]
39. ALK Positive Anaplastic Large Cell Lymphoma With Pure Leptomeningeal Involvement: Unique Case Report and Review of the Literature.
Bricker PC; Lesley WS; Surapaneni R
Clin Neuroradiol; 2015 Jun; 25(2):177-9. PubMed ID: 24407988
[No Abstract] [Full Text] [Related]
40. Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders.
Samols MA; Su A; Ra S; Cappel MA; Louissant A; Knudson RA; Ketterling RP; Said J; Binder S; Harris NL; Feldman AL; Kim J; Kim YH; Gratzinger D
Am J Surg Pathol; 2014 Sep; 38(9):1203-11. PubMed ID: 24805854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
